Discovery from Charles River delivers world-class science
Charles River is industry-proven in the successful development of novel therapies, with over 320 patents and 77 preclinical drug candidates delivered to clients in the past 17 years. Our comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services from the earliest stages of hit identification all the way through to IND. Our client-focused, collaborative approach creates partnerships that anticipate challenges, overcome obstacles, and drive new drugs to market.
251 Ballardvale St
Wilmington, MA 01887